1. Home
  2. ELTX vs MRCC Comparison

ELTX vs MRCC Comparison

Compare ELTX & MRCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Elicio Therapeutics Inc.

ELTX

Elicio Therapeutics Inc.

HOLD

Current Price

$12.75

Market Cap

134.1M

Sector

Health Care

ML Signal

HOLD

Logo Monroe Capital Corporation

MRCC

Monroe Capital Corporation

HOLD

Current Price

$4.86

Market Cap

135.8M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
ELTX
MRCC
Founded
2011
2011
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Investment Managers
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
134.1M
135.8M
IPO Year
2014
2011

Fundamental Metrics

Financial Performance
Metric
ELTX
MRCC
Price
$12.75
$4.86
Analyst Decision
Strong Buy
Hold
Analyst Count
1
1
Target Price
$13.00
$8.00
AVG Volume (30 Days)
144.9K
107.4K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
11.94%
EPS Growth
38.94
2150.00
EPS
N/A
N/A
Revenue
$2,301,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$4.60
$5.70
52 Week High
$14.93
$8.29

Technical Indicators

Market Signals
Indicator
ELTX
MRCC
Relative Strength Index (RSI) 70.47 24.41
Support Level $7.78 N/A
Resistance Level N/A $6.91
Average True Range (ATR) 1.02 0.30
MACD 0.43 -0.08
Stochastic Oscillator 68.83 9.21

Price Performance

Historical Comparison
ELTX
MRCC

About ELTX Elicio Therapeutics Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company pioneering the development of cancer immunotherapies for patients with limited treatment options and poor outcomes. Its proprietary Amphiphile, or AMP, platform delivers investigational immunotherapeutics directly to the brain center of the immune system the lymph nodes. Its focus is the development of cancer immunotherapies against biologically validated but hard-to-drug targets that can be activated through lymph node trafficking.

About MRCC Monroe Capital Corporation

Monroe Capital Corp is a speciality finance company focused on providing financing to lower middle-market companies, in the U.S. and Canada. The company provides customized financing solutions focused on senior, unitranche, and junior secured debt and unsecured subordinated debt and equity, including equity co-investments in preferred and common stock and warrants.

Share on Social Networks: